Regal Wealth Group’s AbbVie ABBV Stock Holding History

Regal Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	-$2K	–	51
2021 Q1	$2K	Buy	+15	New	+$1.6K	﹤0.01%	214
2016 Q4	–	Sell	-71	Closed	-$4K	–	157
2016 Q3	$4K	Hold	71	–	–	﹤0.01%	147
2016 Q2	$4K	Buy	+71	New	+$4.33K	﹤0.01%	152

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Regal Wealth Group's ABBV Position: Q2 2021 in Review

Regal Wealth Group sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 15 shares — an estimated $2K sold.

Regal Wealth Group first reported a position in ABBV in Q2 2016 and held it in 3 quarters. The position peaked at $4K in Q3 2016. 2,676 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Regal Wealth Group reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
Regal Wealth Group sold 15 AbbVie shares in Q2 2021, an estimated $2K.
Regal Wealth Group first reported a position in AbbVie in Q2 2016 and held it in 3 quarters.
Regal Wealth Group's AbbVie position peaked at $4K in Q3 2016.
2,676 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Regal Wealth Group's 13F filing for Q2 2021, filed 2 Aug 2021.